Attached files

file filename
EX-10.35 - EXHIBIT 10.35 - BELLICUM PHARMACEUTICALS, INCexhibit1035_firstamendment.htm
10-K - 10-K - BELLICUM PHARMACEUTICALS, INCa201910k1.htm
EX-32.2 - EXHIBIT 32.2 - BELLICUM PHARMACEUTICALS, INCexh322certcfosox2019q4.htm
EX-32.1 - EXHIBIT 32.1 - BELLICUM PHARMACEUTICALS, INCexh321certceosox2019q4.htm
EX-31.2 - EXHIBIT 31.2 - BELLICUM PHARMACEUTICALS, INCexh312certofcfo2019q4.htm
EX-31.1 - EXHIBIT 31.1 - BELLICUM PHARMACEUTICALS, INCexh311certofceo2019q4.htm
EX-23.1 - EXHIBIT 23.1 - BELLICUM PHARMACEUTICALS, INCbellicum-ex231consentofey19.htm
EX-10.5(B) - EXHIBIT 10.5(B) - BELLICUM PHARMACEUTICALS, INCexhibit105b_2019equityince.htm
EX-10.39 - EXHIBIT 10.39 - BELLICUM PHARMACEUTICALS, INCexhibit1039_firstamendment.htm
EX-10.38 - EXHIBIT 10.38 - BELLICUM PHARMACEUTICALS, INCexhibit1038_mdaassetpurcha.htm
EX-10.6 - EXHIBIT 10.6 - BELLICUM PHARMACEUTICALS, INCexhibit106_directorcompens.htm
EX-4.7 - EXHIBIT 4.7 - BELLICUM PHARMACEUTICALS, INCexhibit47_descriptionofsec.htm
EX-3.1 - EXHIBIT 3.1 - BELLICUM PHARMACEUTICALS, INCexhibit31_amendedrestatedc.htm
Exhibit 21.1

Subsidiaries of Bellicum Pharmaceuticals, Inc.
as of December 31, 2019

Bellicum Pharma Limited, a private limited company organized under the laws of the United Kingdom

Bellicum Pharma GmbH, a private limited liability company organized under the laws of Germany